Utrecht-based TargED Biopharmaceuticals raises €39M, to target clinical development of thrombolytic treatment
TargED Biopharmaceuticals, an Utrecht-based biotechnology company focused on developing improved treatments for thrombotic diseases, announced that it has secured €39M...